← Leaderboards
Sabita Roy
University Of Minnesota Twin Cities
$24,863,892
Attributed
$30,372,016
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,372,016 · 20
By mechanism
R01$25,894,249 · 11
P50$1,082,286 · 3
T32$1,044,074 · 1
K02$977,400 · 1
K05$660,960 · 1
R21$439,280 · 1
Top collaborators
- Sundaram Ramakrishnan11 shared
- Shuanglin Hao5 shared
- Timothy J Johnson5 shared
- Thomas William Molitor5 shared
- Noula Dattu Shembade4 shared
- Allison Michelle Andrews1 shared
- Howard Eliot Gendelman1 shared
- Enrique A Mesri1 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Jinghua Wang$166,727
Others in their field
Top investigators on “Morphine”
- Abhik Das · Research Triangle Institute$25,628,714
- Jeffrey Reich · Sparian Biosciences, Inc.$21,990,518
- Sandra D. Comer · New York State Psychiatric Institute$18,481,203
- Ying-Xian Pan · Sloan-Kettering Institute For Cancer Res$18,192,035
- Shilpa J Buch · University Of Kansas Medical Center$17,492,222
- Charles P France · University Of Texas Hlth Science Center$17,120,824
Research focus
MorphineChronicDrug AbuseOpioidInfectionCytokineHiv InfectionsAttenuatedPredispositionImmuneOpioid AbuseAcquired Immunodeficiency SyndromeHiv-1ReportingDrug UsageDisease ProgressionDrug AbuserAnimalsMouse ModelCellsSignal TransductionDrug UserMicrobialProteins
Grant awards (108)
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$616,751
R01 · FY2025 · CA
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection$232,410
R21 · FY2025 · DA · contact PI
29th-31st Scientific Conference Society on NeuroImmune Pharmacology$1
R13 · FY2025 · DA
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$607,897
R01 · FY2024 · CA
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection$206,870
R21 · FY2024 · DA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$599,301
R01 · FY2023 · CA
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$378,669
R01 · FY2023 · DA · contact PI
Multidisciplinary Training in Substance Abuse Research$128,513
T32 · FY2023 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$44,265
R01 · FY2023 · DA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$590,958
R01 · FY2022 · CA
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2022 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$378,669
R01 · FY2022 · DA · contact PI
Multidisciplinary Training in Substance Abuse Research$270,119
T32 · FY2022 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$153,500
R01 · FY2022 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$44,265
R01 · FY2022 · DA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$578,253
R01 · FY2021 · CA
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression$504,127
R01 · FY2021 · DA · contact PI
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis$501,885
R01 · FY2021 · DK · contact PI
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy$499,558
R01 · FY2021 · DA · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,518
R01 · FY2021 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$378,669
R01 · FY2021 · DA · contact PI
Multidisciplinary Training in Substance Abuse Research$255,946
T32 · FY2021 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$153,500
R01 · FY2021 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$84,608
R01 · FY2021 · DA · contact PI
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression$622,803
R01 · FY2020 · DA · contact PI
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy$509,400
R01 · FY2020 · DA · contact PI
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis$501,885
R01 · FY2020 · DK · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2020 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$379,679
R01 · FY2020 · DA · contact PI
Multidisciplinary Training in Substance Abuse Research$252,460
T32 · FY2020 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$84,608
R01 · FY2020 · DA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$55,125
R25 · FY2020 · DA
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression$622,803
R01 · FY2019 · DA · contact PI
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy$518,963
R01 · FY2019 · DA · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,518
R01 · FY2019 · DA · contact PI
Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV$377,433
R01 · FY2019 · DA · contact PI
Multidisciplinary Training in Substance Abuse Research$137,036
T32 · FY2019 · DA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$55,434
R25 · FY2019 · DA
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression$622,513
R01 · FY2018 · DA · contact PI
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation$558,924
R01 · FY2018 · DA · contact PI
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy$528,237
R01 · FY2018 · DA · contact PI
Role of Gut Microbiome in HIV/Opioid Induced Peripheral Neuropathy$464,517
R01 · FY2018 · DA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$56,495
R25 · FY2018 · DA
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression$593,000
R01 · FY2017 · DA · contact PI
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation$572,300
R01 · FY2017 · DA · contact PI
Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy$537,250
R01 · FY2017 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$345,375
R01 · FY2017 · DA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$53,621
R25 · FY2017 · DA
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation$561,639
R01 · FY2016 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$173,028
R01 · FY2016 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$155,473
R01 · FY2016 · DA · contact PI
Opioid Drug abuse in the context of opportunistic infection increases susceptibil$132,192
K05 · FY2016 · DA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$53,091
R25 · FY2016 · DA
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation$558,801
R01 · FY2015 · DA · contact PI
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$334,653
R01 · FY2015 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$326,887
R01 · FY2015 · DA · contact PI
Opioid Drug abuse in the context of opportunistic infection increases susceptibil$132,192
K05 · FY2015 · DA · contact PI
Gut microbiota disruption by Morphine and in the context of HIV infection contributes to sustained immune activation$567,312
R01 · FY2014 · DA · contact PI
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2014 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$331,909
R01 · FY2014 · DA · contact PI
Opioid Drug abuse in the context of opportunistic infection increases susceptibil$132,192
K05 · FY2014 · DA · contact PI
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$326,160
R01 · FY2013 · DA · contact PI
Opioid Abuse, opportunistic infection and NeuroAIDS$317,628
R01 · FY2013 · DA · contact PI
Mechanism underlying Morphine modulation of gut barrier function in the Context o$309,957
R01 · FY2013 · DA · contact PI
Opioid Drug abuse in the context of opportunistic infection increases susceptibil$132,192
K05 · FY2013 · DA · contact PI
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2012 · DA · contact PI
Opioid Abuse, opportunistic infection and NeuroAIDS$332,956
R01 · FY2012 · DA · contact PI
Chronic Morphine and Morphine Withdrawal Modulate Macrophage Function$155,915
P50 · FY2012 · DA · contact PI
Opioid Drug abuse in the context of opportunistic infection increases susceptibil$132,192
K05 · FY2012 · DA · contact PI
Role of microRNAs in opioid drug abuse induced persistent Inflammation and HIV di$339,750
R01 · FY2011 · DA · contact PI
Opioid Abuse, opportunistic infection and NeuroAIDS$332,956
R01 · FY2011 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$274,815
R01 · FY2011 · DA · contact PI
Chronic Morphine and Morphine Withdrawal Modulate Macrophage Function$156,408
P50 · FY2011 · DA · contact PI
Role of Mu Opioid Receptor in Immune Function$126,749
K02 · FY2011 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$433,003
R01 · FY2010 · DA · contact PI
Opioid Abuse, opportunistic infection and NeuroAIDS$346,040
R01 · FY2010 · DA · contact PI
Role of Mu Opioid Receptor in Immune Function$126,749
K02 · FY2010 · DA · contact PI
Chronic Morphine and Morphine Withdrawal Modulate Macrophage Function$51,347
P50 · FY2010 · DA · contact PI
Opioid Abuse, opportunistic infection and NeuroAIDS$355,635
R01 · FY2009 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$286,570
R01 · FY2009 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$151,000
R01 · FY2009 · DA · contact PI
Role of Mu Opioid Receptor in Immune Function$126,749
K02 · FY2009 · DA · contact PI
Chronic Morphine and Morphine Withdrawal Modulate Macrophage Function$54,103
P50 · FY2009 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$286,757
R01 · FY2008 · DA · contact PI
Chronic Morphine and Morphine Withdrawal Modulate Macrophage Function$146,199
P50 · FY2008 · DA · contact PI
Role of Mu Opioid Receptor in Immune Function$126,749
K02 · FY2008 · DA · contact PI
Morphine, HIV proteins, wound healing and Infection$292,796
R01 · FY2007 · DA · contact PI
MU Opioid Receptor and Immune Function$285,524
R01 · FY2007 · DA · contact PI
MU-Opioid Receptor in Stress Induced Immunosupression$109,849
P50 · FY2007 · DA · contact PI
Role of Mu Opioid Receptor in Immune Function$98,941
K02 · FY2007 · DA · contact PI
MU Opioid Receptor and Immune Function$253,769
R01 · FY2006 · DA · contact PI
Role of Mu Opiod Receptor in Immune Function$90,231
K02 · FY2006 · DA · contact PI
MU Opioid Receptor and Immune Function$40,283
R01 · FY2006 · DA · contact PI
MU Opioid Receptor and Immune Function$298,857
R01 · FY2005 · DA
Role of Mu Opiod Receptor in Immune Function$72,213
K02 · FY2005 · DA
MU Opioid Receptor and Immune Function$245,428
R01 · FY2004 · DA
Role of Mu Opiod Receptor in Immune Function$69,673
K02 · FY2004 · DA
MU Opioid Receptor and Immune Function$36,634
R01 · FY2004 · DA
Mu Opioid Receptor and Immune Function$254,971
R01 · FY2003 · DA
Role of Mu Opiod Receptor in Immune Function$69,673
K02 · FY2003 · DA
MU OPIOID RECEPTOR AND IMMUNE FUNCTION$210,213
R01 · FY2002 · DA
Role of Mu Opiod Receptor in Immune Function$69,673
K02 · FY2002 · DA
INHIBITION OF CYTOKINE GENE EXPRESSION BY MORPHINE$0
P50 · FY2002 · DA
MU OPIOID RECEPTOR AND IMMUNE FUNCTION$200,247
R01 · FY2001 · DA
INHIBITION OF CYTOKINE GENE EXPRESSION BY MORPHINE$0
P50 · FY2001 · DA
INHIBITION OF CYTOKINE GENE EXPRESSION BY MORPHINE$408,465
P50 · FY2000 · DA
MU OPIOID RECEPTOR AND IMMUNE FUNCTION$155,101
R01 · FY2000 · DA
MU OPIOID RECEPTOR AND IMMUNE FUNCTION$25,362
R01 · FY2000 · DA